Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Publication|Articles|November 10, 2026
- November 2026
- Volume 92
- Issue 11
Why Wait for Retirement? Build Meaningful Breaks Into Your Pharmacy Career
Author(s)Tim Ulbrich, PharmD
Fact checked by: Tracy Ann Politowicz
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Advertisement
Advertisement
For many pharmacists, retirement is when we will finally have more freedom to travel, spend time with family, pursue an interest, or simply slow down. We work, save, and invest with that future in mind. But what if some of those experiences belong earlier in our lives?
Related to this article
Christie Ballantyne, MD, explains how the CORALreef Extension study adds safety exposure and shows LDL-C lowering with oral enlicitide is sustained over time.
The glucagon/GLP-1 dual agonist did not raise major adverse cardiovascular event risk in adults with obesity, but GI-related discontinuations were high.
Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Post hoc AHA 2026 data show the oral GLP-1 receptor agonist lowered systolic blood pressure across hypertension stages, partly beyond weight loss.
The evidence for GLP-1 receptor agonists keeps growing, while access for low-income patients keeps narrowing.
Specialty pharmacists can help patients with cancer weigh the benefits and risks of GLP-1 receptor agonists as use expands and new evidence emerges.
Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
Advertisement
Advertisement